The Clinical Utility of the Congo-Red Dot Test for Diagnosis and Early Prediction of Preeclampsia During Pregnancy

Completed

Conditions studied: Preeclampsia

In brief

The aim of the study is to validate in a prospective fashion the value of the Congo-Red Dot (CRD) test for diagnosis of preeclampsia. The working hypothesis is that in pregnancies complicated by preeclampsia, will display urine congophilia and have a positive CRD test.

Key facts

Study ID

NCT02455544

Run by

Catalin S Buhimschi, MD

People needed

346

Starts

2014-08-01

Expected to finish

2018-08-01

Last updated by the study team

2018-10-09

Who can join

Age: 18 and older, up to 48. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant women evaluated for the onset of clinical symptoms of preeclampsia in the Labor and Delivery Unit of The Ohio State Wexner Medical Center.

You may not qualify if…

• Non-english speaking
• Men
• Prisoners
• Those unable to provide consent for themselves

Where it is running

• The Ohio State Medical Center Labor and Delivery Unit — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.